Stocks / NYSE / GlaxoSmithKline PLC

GlaxoSmithKline PLC

Our Opinion

GlaxoSmithKline PLC is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in its Animal Testing policy that they conduct pre-clinical trials of their drugs on animals.

“We have a company-wide policy that covers the standards of care and the ethical treatment of animals in research.” Read the full article.

Company Description

GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands. It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare. The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases. The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis. The Consumer Healthcare business markets a range of consumer health products based on scientific innovation. The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom. [Source: MarketWatch]

Company Website: https://www.gsk.com